Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Cencora
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Acquisitions=== *In 2011, the company acquired IntrinsiQ for $35 million and Premier Source for an undisclosed amount.<ref>{{Cite web|date=6 September 2011|title=AmerisourceBergen buys IntrinsiQ|url=https://www.bizjournals.com/philadelphia/news/2011/09/06/amerisourcebergen-buys-intrinsiq.html|website=Philadelphia Business Journal}}</ref><ref>{{Cite web|date=2011-09-02|title=AmerisourceBergen buys Premier Source|url=https://oklahoman.com/article/feed/291805/amerisourcebergen-buys-premier-source/|access-date=2020-07-17|website=The Oklahoman|language=en-US|archive-date=July 17, 2020|archive-url=https://web.archive.org/web/20200717171313/http://oklahoman.com/article/feed/291805/amerisourcebergen-buys-premier-source|url-status=dead}}</ref> In July, [[Steven H. Collis|Steven Collis]] replaced Yost as CEO of the company.<ref name=":1" /> *In March 2012, AmerisourceBergen agreed to acquire World Courier Group Inc, a transportation and logistics provider for the biopharmaceutical industry, for $520 million.<ref>{{Cite web|last=Sell|first=David|date=6 March 2012|title=AmerisourceBergen to acquire World Courier Group|url=https://www.inquirer.com/philly/blogs/phillypharma/AmerisourceBergen-to-Acquire-World-Courier-Group-Inc.html|access-date=2020-07-17|website=The Philadelphia Inquirer|language=en-US}}</ref> *In January 2015, the company bought MWI Veterinary for $2.5 billion. In October,<ref name=":0">{{Cite news|date=2015-10-06|title=AmerisourceBergen to buy PharMEDium for $2.58 billion|language=en|work=Reuters|url=https://www.reuters.com/article/us-pharmedium-m-a-amerisourcebergn-idUSKCN0S019P20151006|access-date=2020-07-17}}</ref> they agreed to buy PharMEDium, a compounding drug company, for $2.58 billion.<ref name=":0" /> *On January 3, 2018, AmerisourceBergen acquired H. D. Smith, the largest privately-held national pharmaceutical [[wholesaler]] in the U.S.<ref>{{Cite web|title=AmerisourceBergen Completes Acquisition of HD Smith|url=https://www.amerisourcebergen.com/abcnew/newsroom/press-releases/amerisourcebergen-completes-acquisition-of-hd-smith|access-date=2018-09-25|website=AmerisourceBergen|language=en|archive-date=September 26, 2018|archive-url=https://web.archive.org/web/20180926052007/https://www.amerisourcebergen.com/abcnew/newsroom/press-releases/amerisourcebergen-completes-acquisition-of-hd-smith|url-status=dead}}</ref><ref>{{Cite web|last=Olsen|first=Dean|title=Former H.D. Smith workforce reducing to 25 locally|url=https://www.sj-r.com/news/20190404/former-hd-smith-workforce-reducing-to-25-locally|access-date=2020-07-17|website=The State Journal-Register|language=en|archive-date=July 17, 2020|archive-url=https://web.archive.org/web/20200717172332/https://www.sj-r.com/news/20190404/former-hd-smith-workforce-reducing-to-25-locally|url-status=dead}}</ref> *On June 2, 2021, AmerisourceBergen acquired Alliance Healthcare from [[Walgreens Boots Alliance]] for approximately $6.5 billion, made up of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock.<ref>{{Cite press release|title=Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen Divesting Alliance Healthcare Businesses|url=https://www.businesswire.com/news/home/20210602005360/en/Walgreens-Boots-Alliance-Completes-Strategic-Transaction-with-AmerisourceBergen-Divesting-Alliance-Healthcare-Businesses|website=Businesswire|language=en}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)